검색어 : 통합검색[Levine Adam]
총 979건 중 979건 출력
, 98/98 페이지
-
971
- MM-219: Pivotal DREAMM-2 Study: Single-Agent Belantamab Mafodotin (Belamaf; GSK2857916) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Refractory to Proteasome Inhibitors and Immunomodulatory Agents, and Refractory and/or Intolerant to Anti-CD38 Monoclonal Antibodies (mAbs), Including Subgroups with Renal Impairment (RI) and High-Risk (HR) Cytogenetics
- Lonial, Sagar; Lee, Hans Chulhee; Badros, Ashraf; Trudel, Suzanne; Nooka, Ajay K; Chari, Ajai; Abdallah, Al-Ola; Callander, Natalie Scott; Sborov, Douglas Weston; Suvannasankha, Attaya; Weisel, Katja; Voorhees, Peter M; Hultcrantz, Malin; Libby, Edward N; Richardson, Paul G; Otero, Paula Rodriguez; Besemer, Britta; Facon, Thierry; Hoos, Axel; Zhi, Eric; Baron, January; Piontek, Trisha; Jewell, Roxanne C; Lewis, Eric; Opalinska, Joanna; Gupta, Ira; Cohen, Adam D; Emory University, Winship Cancer Institute; MD Anderson Cancer Center; University of Maryland at Baltimore; Princess Margaret Cancer Centre; Emory University, Winship Cancer Institute; Icahn School of Medicine at Mount Sinai; University of Kansas Cancer Center; University of Wisconsin, Carbone Cancer Center; Huntsman Cancer Institute, University of Utah, Salt Lake City; Indiana University Cancer Center; Medical Center of Hamburg-Eppendorf; Levine Cancer Institute, Atrium Health; Memorial Sloan Kettering Cancer Center; Division of Medical Oncology, University of Washington; Dana Farber Cancer Institute; Clí nica Universi; (Clinical lymphoma, myeloma & leukemia, v.20, 2020, pp.S301-S302)
-
972
- Cytokine Release Syndrome in Patients with Relapsed/Refractory Multiple Myeloma Treated with Ciltacabtagene Autoleucel in the Phase 1b/2 CARTITUDE-1 Study
- Lin, Yi; Martin III, Thomas; Cohen, Adam D.; Jakubowiak, Andrzej; Jasielec, Jagoda; Usmani, Saad Z.; Madduri, Deepu; Agha, Mounzer; Stewart, A. Keith; Singh, Indrajeet; Zudaire, Enrique; Yeh, Tzu-Min; Allred, Alicia J.; Olyslager, Yunsi; Banerjee, Arnob; Goldberg, Jenna D.; Schecter, Jordan M.; Jackson, Carolyn C.; Deraedt, William; Geng, Dong; Wu, Xiaoling; Carrasco, Marlene J.; Akram, Muhammad; Hossain, Farah; Wang, Vickie; Berdeja, Jesus G.; Jagannath, Sundar; Division of Hematology, Mayo Clinic, Rochester, MN; University of California, San Francisco, San Francisco, CA; Perelman Center, University of Pennsylvania, Philadelphia, PA; University of Chicago, Chicago, IL; University of Chicago, Chicago, IL; Levine Cancer Institute, Charlotte, NC; Mount Sinai Medical Center, New York, NY; UPMC Hillman Cancer Center, Pittsburgh, PA; UHN and the Princess Margaret Cancer Centre, Toronto, Canada; Janssen R&D, Spring House, PA; Janssen R&D, Spring House, PA; Janssen R&D, Raritan, NJ; Janssen R&D, Spring House, PA; Janssen R&D, Beerse, Belgium; Janssen R&D, Spring House, PA; Janssen R&D, Raritan, NJ; Janssen R&D, Raritan, NJ; Janssen R&D, Raritan, NJ; Janssen R&D, Beerse, Belgium; Legend Biotech USA Inc., Piscataway, NJ; Legend Biotech USA Inc., Piscataway, NJ; Legend Biotech USA Inc., Piscataway, NJ; Legend Biotech USA Inc., Piscataway, NJ; Legend Biotech USA Inc., Piscataway, NJ; Legend Biotech USA Inc., Piscataway, NJ; Sarah; (Blood, v.136, 2020, pp.45-46)
-
973
- CARTITUDE-1: Phase 1b/2 Study of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy, in Relapsed/Refractory Multiple Myeloma
- Madduri, Deepu; Berdeja, Jesus G.; Usmani, Saad Z.; Jakubowiak, Andrzej; Agha, Mounzer; Cohen, Adam D.; Stewart, A. Keith; Hari, Parameswaran; Htut, Myo; O'Donnell, Elizabeth; Munshi, Nikhil C.; Avigan, David E.; Deol, Abhinav; Lesokhin, Alexander M.; Singh, Indrajeet; Zudaire, Enrique; Yeh, Tzu-Min; Allred, Alicia J.; Olyslager, Yunsi; Banerjee, Arnob; Goldberg, Jenna D.; Schecter, Jordan M.; Jackson, Carolyn C.; Deraedt, William; Zhuang, Sen Hong; Infante, Jeffrey R.; Geng, Dong; Wu, Xiaoling; Carrasco, Marlene J.; Akram, Muhammad; Hossain, Farah; Rizvi, Syed; Fan, Frank; Jagannath, Sundar; Lin, Yi; Martin III, Thomas; Mount Sinai Medical Center, New York, NY; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN; Levine Cancer Institute, Charlotte, NC; University of Chicago, Chicago, IL; UPMC Hillman Cancer Center, Pittsburgh, PA; University of Pennsylvania, Abramson Cancer Center, Philadelphia, PA; UHN and the Princess Margaret Cancer Centre, Toronto, Canada; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; City of Hope Comprehensive Cancer Center, Duarte, CA; Department of Hematology/Oncology, Massachusetts General Hospital, Boston, MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; Department of Oncology, Blood and Marrow Stem Cell Transplant Program, Karmanos Cancer Institute/Wayne State University, Detroit, MI; Memorial Sloan Kettering Cancer Center, New York, NY; Janssen R&D, Spring; (Blood, v.136, 2020, pp.22-25)
-
974
- Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma
- Herrera, Alex F.; LeBlanc, Michael; Castellino, Sharon M.; Li, Hongli; Rutherford, Sarah C.; Evens, Andrew M.; Davison, Kelly; Punnett, Angela; Parsons, Susan K.; Ahmed, Sairah; Casulo, Carla; Bartlett, Nancy L.; Tuscano, Joseph M.; Mei, Matthew G.; Hess, Brian T.; Jacobs, Ryan; Saeed, Hayder; Torka, Pallawi; Hu, Boyu; Moskowitz, Craig; Kaur, Supreet; Goyal, Gaurav; Forlenza, Christopher; Doan, Andrew; Lamble, Adam; Kumar, Pankaj; Chowdhury, Saeeda; Brinker, Brett; Sharma, Namita; Singh, Avina; Blum, Kristie A.; Perry, Anamarija M.; Kovach, Alexandra E.; Hodgson, David; Constine, Louis S.; Shields, Lale Kostakoglu; Prica, Anca; Dillon, Hildy; Little, Richard F.; Shipp, Margaret A.; Crump, Michael; Kahl, Brad; Leonard, John P.; Smith, Sonali M.; Song, Joo Y.; Kelly, Kara M.; Friedberg, Jonathan W.; City of Hope Comprehensive Cancer Center, Duarte, CA; SWOG Statistics and Data Management Center, Seattle, WA; Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Emory University Hospital/Winship Cancer Institute, Atlanta, GA; SWOG Statistics and Data Management Center, Seattle, WA; Weill Cornell Medicine, New York, NY; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; McGill University Health Centre, Montreal, Quebec, CAN; SickKids Hospital, Toronto, Ontario, CAN; Reid R. Sacco AYA Cancer Program, Tufts Medical Center, Boston, MA; MD Anderson Cancer Center, Houston, TX; Wilmot Cancer Institute, University of Rochester, Rochester, NY; Siteman Cancer Center, Washington University, St. Louis, MO; UC Davis Comprehensive Cancer Center, Sacramento, CA; City of Hope Comprehensive Cancer Center, Duarte, CA; Medical University of South Carolina, Charleston, SC; Carolinas Medical Center/Levine Cancer Institute, Charlotte, NC; Moffitt Cancer Cen; (The New England journal of medicine, v.391, 2024, pp.1379-1389)
-
975
- Safety and effectiveness of abatacept in juvenile idiopathic arthritis: results from the PRINTO/PRCSG registry
- Lovell, Daniel J; Tzaribachev, Nikolay; Henrickson, Michael; Simonini, Gabriele; Griffin, Thomas A; Alexeeva, Ekaterina; Bohnsack, John F; Zeft, Andrew; Horneff, Gerd; Vehe, Richard K; Staņ ē vič a, Valda; Tarvin, Stacey; Trachana, Maria; del Rí o, Ana Quintero; Huber, Adam M; Kietz, Daniel; Orbá n, Ilonka; Dare, Jason; Foeldvari, Ivan; Quartier, Pierre; Dominique, Alyssa; Simon, Teresa A; Martini, Alberto; Brunner, Hermine I; Ruperto, Nicolino; Brunner, Jurgen; Fernandes, Taciana; Appenzeller, Simone; Oliveira, Sheila; Terreri, Maria Teresa; Tzaribachev, Nikolay; Minden, Kirsten; Hufnagel, Mark; Foeldvari, Ivan; Horneff, Gerd; Helling-Bakki, Astrid; Herlin, Troels; Moreno, Estefania; Anton, Jordi; del-Castillo, Pablo Mesa-; Udaondo, Clara; Penades, Inmaculada Calvo; Quartier, Pierre; Brochard, Karine; Ramanan, Athimalaipet; Trachana, Maria; Orban, Ilonka; Hashkes, Philip (Pinchas); Ruperto, Nicolino; Simonini,; Division of Rheumatology, Cincinnati Children’s Hospital Medical Center, University of Cincinnati , Cincinnati, OH, USA; PRI Research , Bad Bramstedt, Germany; Division of Rheumatology, Cincinnati Children’s Hospital Medical Center, University of Cincinnati , Cincinnati, OH, USA; IRCCS Meyer Children’s Hospital, Rheumatology Unit, ERN-ReCONNECT Center , Florence, Italy; Atrium Health, Levine Children’s Hospital , Charlotte, NC, USA; Department of Rheumatology, National Medical Research Center of Children’s Health , Moscow, Russia; Division of Allergy, Immunology and Pediatric Rheumatology, University of Utah , Salt Lake City, UT, USA; Center for Pediatric Rheumatology and Immunology, Cleveland Clinic , Cleveland, OH, USA; Asklepios Clinic Sankt Augustin , Sankt Augustin, Germany; Department of Pediatrics, Division of Pediatric Rheumatology, University of Minnesota , Minneapolis, MN, USA; Riga Stradins University , Riga, Latvia; Riley Hospital for Children at Indian; (Rheumatology, v.63, 2024, pp.SI195-SI206)
-
976
- Postibrutinib relapse outcomes for patients with marginal zone lymphoma
- Epperla, Narendranath; Zhao, Qiuhong; Chowdhury, Sayan Mullick; Shea, Lauren; Moyo, Tamara K.; Reddy, Nishitha; Sheets, Julia; Weiner, David M.; Geethakumari, Praveen Ramakrishnan; Kandarpa, Malathi; Bruno, Ximena Jordan; Thomas, Colin; Churnetski, Michael C.; Hsu, Andrew; Zurbriggen, Luke; Tan, Xiao-wei Cherie; Lindsey, Kathryn; Maakaron, Joseph; Caimi, Paolo F.; Torka, Pallawi; Bello, Celeste; Ayyappan, Sabarish; Oh, Timothy S.; Karmali, Reem; Kim, Seo-Hyun; Kress, Anna; Kothari, Shalin; Sawalha, Yazeed; Christian, Beth; David, Kevin A.; Greenwell, Irl Brian; Janakiram, Murali; Kenkre, Vaishalee P.; Olszewski, Adam J.; Cohen, Jonathon B.; Palmisiano, Neil; Umyarova, Elvira; Wilcox, Ryan A.; Awan, Farrukh T.; Alderuccio, Juan Pablo; Barta, Stefan K.; Grover, Natalie S.; Ghosh, Nilanjan; Bartlett, Nancy L.; Herrera, Alex F.; Shouse, Geoffrey; Division of Hematology, The Ohio State University, Columbus, OH; Division of Hematology, The Ohio State University, Columbus, OH; Division of Hematology, The Ohio State University, Columbus, OH; Division of Hematology, Washington University, St. Louis, MO; Levine Cancer Center, Atrium Health, Charlotte, NC; Vanderbilt University Medical Center, Nashville, TN; Division of Hematology and Oncology, University of North Carolina, Chapel Hill, NC; Division of Hematology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX; Division of Hematology, Rogel Cancer Center, University of Michigan, Ann Arbor, MI; Division of Hematology and Oncology, University of Vermont, Burlington, VT; Division of Hematology, Thomas Jefferson University, Philadelphia, PA; Winship Cancer Institute, Emory University Medical Center, Atlanta, GA; Division of Hematology, Brown U; (Blood advances, v.7, 2023, pp.88-91)
-
977
- Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study
- Epperla, Narendranath; Zhao, Qiuhong; Chowdhury, Sayan Mullick; Shea, Lauren; Moyo, Tamara K.; Reddy, Nishitha; Sheets, Julia; Weiner, David M.; Geethakumari, Praveen Ramakrishnan; Kandarpa, Malathi; Bruno, Ximena Jordan; Thomas, Colin; Churnetski, Michael C.; Hsu, Andrew; Zurbriggen, Luke; Tan, Cherie; Lindsey, Kathryn; Maakaron, Joseph; Caimi, Paolo F.; Torka, Pallawi; Bello, Celeste; Ayyappan, Sabarish; Karmali, Reem; Kim, Seo-Hyun; Kress, Anna; Kothari, Shalin; Sawalha, Yazeed; Christian, Beth; David, Kevin A.; Greenwell, Irl Brian; Janakiram, Murali; Kenkre, Vaishalee P.; Olszewski, Adam J.; Cohen, Jonathon B.; Palmisiano, Neil; Umyarova, Elvira; Wilcox, Ryan A.; Awan, Farrukh T.; Alderuccio, Juan Pablo; Barta, Stefan K.; Grover, Natalie S.; Ghosh, Nilanjan; Bartlett, Nancy L.; Herrera, Alex F.; Shouse, Geoffrey; Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH 43210 USA; Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH 43210 USA; Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH 43210 USA; Washington University, St. Louis, MO USA; Levine Cancer Center, Atrium Health, Charlotte, NC USA; Vanderbilt University Medical Center, Nashville, TN USA; University of North Carolina, Chapel Hill, NC USA; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA USA; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX USA; Rogel Cancer Center, University of Michigan, Ann Arbor, MI USA; University of Vermont, Burlington, VT USA; Thomas Jefferson University, Philadelphia, PA USA; Winship Cancer Institute, Emory University Medical Center, Atlanta, GA USA; Brown University, Providence, RI USA; University of; (Journal of hematology & oncology, v.15, 2022, pp.96)
-
978
- Postvaccination Immunogenicity Among Pediatric Solid Organ Transplant Recipients
- Feldman, Amy G.; Beaty, Brenda L.; Ferrolino, Jose A.; Maron, Gabriela; Ali, Saira A.; Bitterfeld, Leandra; Blatt, Adam; Boulware, Mary Alice; Campbell, Kathleen M.; Carr, Emily; Cetin, Benhur; Chapman, Shelley; Chang, Yeh-Chung; Cunningham, Ryan; Dallas, Ronald H.; Dantuluri, Keerti L.; Domenick, Bryanna N.; Ebel, Noelle H.; Elisofon, Scott; Fawaz, Rima; Foca, Marc; Gans, Hayley A.; Gopalareddy, Vani V.; Gupta, Nitika A.; Harmann, Katherine; Hollenbeck, Jessica; Huppler, Anna R.; Jaramillo, Catalina; Kasi, Nagraj; Kerkar, Nanda; Lerret, Stacee; Lobritto, Steven J.; Lopez, M. James; Mavis, Alisha; Mehra, Sonia; Mohandas, Sindhu; Munoz, Flor M.; Mysore, Krupa R.; Ovchinsky, Nadia; Perkins, Kerrigan; Postma, Stacy; Pratscher, Lauren; Rand, Elizabeth B.; Rowe, Regina K.; Ruderfer, Daniel; Schultz, Danielle; Sear, Katherine; Sell, Megan L.; Sharma, Tanvi S.; Stoll, Janis; Turner, Jerry; Valencia Deray, Kristen G.; Villarin, Dominique; We; Digestive Health Institute, Section of Pediatric Gastroenterology, Hepatology and Nutrition, Adult and Child Center for Outcomes Research & Delivery Science (ACCORDS), University of Colorado and Children’s Hospital Colorado, Aurora, Colorado; Adult and Child Center for Outcomes Research & Delivery Science (ACCORDS), University of Colorado, Aurora, Colorado; Department of Infectious Diseases, St. Jude Children’s Research Hospital, Memphis, Tennessee; Department of Infectious Diseases, St. Jude Children’s Research Hospital, Memphis, Tennessee; Children’s Healthcare of Atlanta, Atlanta, Georgia; Intermountain Primary Children’s Hospital, Salt Lake City, Utah; Duke University School of Medicine, Durham, North Carolina; Levine Children’s Hospital at Atrium Health, Wake Forest University School of Medicine, Charlotte, North Carolina; University of Cincinnati College of Medicine, Cincinnati, Ohio; Yale University, New Haven, Connecticut; Erciyes University Faculty of Med; (JAMA pediatrics, v.179, 2025, pp.467)
-
979
- CTNI-17. CLINICAL EFFICACY AND PREDICTIVE BIOMARKERS OF ONC201 IN H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA
- Rahman Kawakibi, Abed; Tarapore, Rohinton S; Gardner, Sharon; Thomas, Chase; Cartaxo, Rodrigo; Yadav, Viveka Nand; Chi, Andrew; Kurz, Sylvia; Wen, Patrick; Arrillaga-Romany, Isabel; Batchelor, Tracy; Butowski, Nicholas; Sumrall, Ashley; Shonka, Nicole; Harrison, Rebecca; de Groot, John; Mehta, Minesh; Odia, Yazmin; Hall, Matthew; Daghistani, Doured; Cloughesy, Timothy; Ellingson, Benjamin; Umemura, Yoshie; Garton, Hugh; Franson, Andrea; Robertson, Patricia; Schwartz, Jonathan; Cantor, Evan; Miklja, Zachary; Mullan, Brendan; Bruzek, Amy; Siada, Ruby; Cummings, Jessica; Paul, Alyssa; Wolfe, Ian; Jiang, Li; Filbin, Mariella; Vats, Pankaj; Kumar-Sinha, Chandan; Mody, Rajen; Chinnaiyan, Arul; Venneti, Sriram; Lu, Guangrong; Mueller, Sabine; Martinez, Daniel; Resnick, Adam; Nazarian, Javad; Waszak, Sebastian; Allen, Joshua; Koschmann, Carl; University of Michigan Medical School, Ann Arbor, MI, USA; Oncoceutics, Inc., Philadelphia, PA, USA; NYU Langone Health, New York, NY, USA; University of Michigan Medical School, Ann Arbor, MI, USA; University of Michigan Medical School, Ann Arbor, MI, USA; University of Michigan Medical School, Ann Arbor, MI, USA; NYU Langone Health, New York, NY, USA; NYU Langone Health, New York, NY, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA; Brigham and Women’s Hospital, Boston, MA, USA; University of California San Francisco, San Francisco, CA, USA; Levine Cancer Institute, Charlotte, NC, USA; University of Nebraska Medical Center, Omaha, NE, USA; University of Texas MD Anderson Cancer Center, Houston, TX, USA; University of Texas MD Anderson Cancer Center, Houston, TX, USA; Miami Cancer Institute, Miami, FL, USA; Miami Cancer Institute, Miami, FL, USA; Miami Cancer Institute, Miami, FL, USA; Miam; (Neuro-oncology, v.22, 2020, pp.ii45-ii46)
QUICK MENU
